Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.80% | 63.94 | 1.0% | $481.30m | |
| AMGN | Amgen, Inc. | -0.72% | 235.04 | 1.3% | $433.22m | |
| BIIB | Biogen, Inc. | -1.35% | 284.21 | 1.4% | $384.69m | |
| ILMN | Illumina, Inc. | -1.21% | 327.00 | 3.5% | $329.26m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.30% | 233.91 | 1.9% | $282.39m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.71% | 356.60 | 2.6% | $239.03m | |
| EXAS | EXACT Sciences Corp. | -2.93% | 92.18 | 24.0% | $232.61m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.56% | 108.55 | 2.0% | $173.61m | |
| INCY | Incyte Corp. | -0.31% | 78.24 | 2.5% | $131.13m | |
| A | Agilent Technologies, Inc. | -1.23% | 89.02 | 1.6% | $127.01m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.93% | 113.68 | 14.6% | $110.30m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -2.24% | 85.63 | 4.3% | $107.80m | |
| SGEN | Seattle Genetics, Inc. | 3.27% | 115.35 | 6.1% | $99.56m | |
| BLUE | bluebird bio, Inc. | -4.35% | 89.72 | 14.2% | $89.98m | |
| DERM | Dermira, Inc. | -0.37% | 18.76 | 3.8% | $83.55m |
Company Profile
Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. Its lead product candidate, inebilizumab, is a humanized monoclonal antibody (mAb), designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells. The company was founded on December 11, 2017 and is headquartered in Gaithersburg, MD.